Improving oncologic outcomes for women with endometrial cancer: Realigning our sights

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 370-374

  Dowdy, Sean C ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Chemotherapy; Endometrial cancer; Radiotherapy; Uterine serous carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADVANCED CANCER; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL OBSERVATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; INTERMEDIATE RISK PATIENT; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; TREATMENT FAILURE;

CHEMOTHERAPY; ENDOMETRIAL CANCER; RADIOTHERAPY; UTERINE SEROUS CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84899638973     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.019     Document Type: Review

References (26)

1. S.C. Dowdy, B.J. Borah, J.N. Bakkum-Gamez, A.L. Weaver, M.E. McGree, and L.R. Haas et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer Gynecol Oncol 127 2012 5 10
2. A. Mariani, S.C. Dowdy, G.L. Keeney, H.J. Long, T.G. Lesnick, and K.C. Podratz High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy Gynecol Oncol 95 2004 120 126
3. A. Mariani, M.J. Webb, G.L. Keeney, G. Calori, and K.C. Podratz Hematogenous dissemination in corpus cancer Gynecol Oncol 80 2001 233 238
4. P. Blake, A.M. Swart, J. Orton, H. Kitchener, T. Whelan, and H. Lukka et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 2009 137 146
5. N. Susumu, S. Sagae, Y. Udagawa, K. Niwa, H. Kuramoto, and S. Satoh et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study Gynecol Oncol 108 2008 226 233
6. T. Hogberg, M. Signorelli, C.F. de Oliveira, R. Fossati, A.A. Lissoni, and B. Sorbe et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies Eur J Cancer 46 2010 2422 2431
7. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 24 2006 36 44
8. D.S. McMeekin, V.L. Filiaci, J.T. Thigpen, H.H. Gallion, G.F. Fleming, and W.H. Rodgers The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study Gynecol Oncol 106 2007 16 22
9. H.D. Homesley, V. Filiaci, S.K. Gibbons, H.J. Long, D. Cella, and N.M. Spirtos et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study Gynecol Oncol 112 2009 543 552
10. C.A. Hamilton, M.K. Cheung, K. Osann, L. Chen, N.N. Teng, and T.A. Longacre et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers Br J Cancer 94 2006 642 646
11. K.M. Alektiar, A. McKee, O. Lin, E. Venkatraman, M.J. Zelefsky, and B. McKee et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer? Int J Radiat Oncol Biol Phys 54 2002 79 85
12. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol Oncol 95 2004 593 596
13. A.N. Fader, D. Starks, P.A. Gehrig, A.A. Secord, H.E. Frasure, and D.M. O'Malley et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Gynecol Oncol 115 2009 244 248
14. M.A. Voss, R. Ganesan, L. Ludeman, K. McCarthy, R. Gornall, and G. Schaller et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer - a clinical and pathological evaluation Gynecol Oncol 124 2012 15 20
15. T.A. Ayeni, J.N. Bakkum-Gamez, A. Mariani, M.E. McGree, A.L. Weaver, and M.G. Haddock et al. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas Gynecol Oncol 129 2013 478 485
16. A.N. Fader, R.D. Drake, D.M. O'Malley, H.E. Gibbons, W.K. Huh, and L.J. Havrilesky et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer 115 2009 2119 2127
17. M.G. Kelly, D.M. O'Malley, P. Hui, J. McAlpine, H. Yu, and T.J. Rutherford et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecol Oncol 98 2005 353 359
18. B.M. Slomovitz, T.W. Burke, P.J. Eifel, L.M. Ramondetta, E.G. Silva, and A. Jhingran et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 2003 463 469
19. M.B. Thomas, A. Mariani, W.A. Cliby, G.A. Keeney, K.C. Podratz, and S.C. Dowdy Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma Gynecol Oncol 107 2007 186 189
20. D. Boll, H.E. Karim-Kos, R.H. Verhoeven, C.W. Burger, J.W. Coebergh, and L.V. van de Poll-Franse et al. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study Eur J Obstet Gynecol Reprod Biol 166 2013 209 214
21. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
22. R. Maggi, A. Lissoni, F. Spina, M. Melpignano, P. Zola, and G. Favalli et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial Br J Cancer 95 2006 266 271
23. A.A. Secord, M.A. Geller, G. Broadwater, R. Holloway, K. Shuler, and N.Y. Dao et al. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer Gynecol Oncol 128 2013 65 70
24. J.N. Bakkum-Gamez, A. Mariani, S.C. Dowdy, A.L. Weaver, M.E. McGree, and J.R. Martin et al. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy Gynecol Oncol 2014 10.1016/j.ygyno.2014.01.007 [Electronic publication ahead of print]
25. C.L. Creutzberg, R.A. Nout, M.L. Lybeert, C.C. Warlam-Rodenhuis, J.J. Jobsen, and J.W. Mens et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma Int J Radiat Oncol Biol Phys 81 2011 e631 e638
26. R.A. Nout, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, L.C. Lutgens, and E.M. van der Steen-Banasik et al. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data Eur J Cancer 48 2012 1638 1648